Boston Scientific Microstimulator Patent Affirmed Invalid

Published May 18, 2020

A Boston Scientific Neuromodulation Corp. patent covering methods for controlling an implantable medical device was correctly invalidated by the Patent Trial and Appeal Board, the Federal Circuit said in a nonprecedential opinion Monday.